Clinical and Therapeutic Considerations for Older Adults with Head and Neck Cancer

Approximately 30% of patients with head and neck squamous cell carcinoma (HNSCC) are at least 70 years of age, and this percentage is expected to increase as the population increases and lives longer. Elderly patients are underrepresented in head and neck oncology clinical trials, and there is minim...

Descripción completa

Detalles Bibliográficos
Autores principales: Dickstein, Daniel R, Powers, Ann E, Vujovic, Dragan, Roof, Scott, Bakst, Richard L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029371/
https://www.ncbi.nlm.nih.gov/pubmed/36959837
http://dx.doi.org/10.2147/CIA.S366155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029371/
https://www.ncbi.nlm.nih.gov/pubmed/36959837
http://dx.doi.org/10.2147/CIA.S366155

Ejemplares similares